Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2014 1
2016 5
2017 7
2018 10
2019 8
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, Kortmann RD, Krex D, Grauer O, Goldbrunner R, Schnell O, Bähr O, Uhl M, Seidel C, Tabatabai G, Kowalski T, Ringel F, Schmidt-Graf F, Suchorska B, Brehmer S, Weyerbrock A, Renovanz M, Bullinger L, Galldiks N, Vajkoczy P, Misch M, Vatter H, Stuplich M, Schäfer N, Kebir S, Weller J, Schaub C, Stummer W, Tonn JC, Simon M, Keil VC, Nelles M, Urbach H, Coenen M, Wick W, Weller M, Fimmers R, Schmid M, Hattingen E, Pietsch T, Coch C, Glas M; Neurooncology Working Group of the German Cancer Society. Herrlinger U, et al. Among authors: schmidt graf f. Lancet. 2019 Feb 16;393(10172):678-688. doi: 10.1016/S0140-6736(18)31791-4. Epub 2019 Feb 14. Lancet. 2019. PMID: 30782343 Clinical Trial.
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
Schaub C, Kebir S, Junold N, Hattingen E, Schäfer N, Steinbach JP, Weyerbrock A, Hau P, Goldbrunner R, Niessen M, Mack F, Stuplich M, Tzaridis T, Bähr O, Kortmann RD, Schlegel U, Schmidt-Graf F, Rohde V, Braun C, Hänel M, Sabel M, Gerlach R, Krex D, Belka C, Vatter H, Proescholdt M, Herrlinger U, Glas M. Schaub C, et al. Among authors: schmidt graf f. J Cancer Res Clin Oncol. 2018 Aug;144(8):1581-1589. doi: 10.1007/s00432-018-2671-z. Epub 2018 May 28. J Cancer Res Clin Oncol. 2018. PMID: 29808316 Clinical Trial.
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Wick W, Roth P, Hartmann C, Hau P, Nakamura M, Stockhammer F, Sabel MC, Wick A, Koeppen S, Ketter R, Vajkoczy P, Eyupoglu I, Kalff R, Pietsch T, Happold C, Galldiks N, Schmidt-Graf F, Bamberg M, Reifenberger G, Platten M, von Deimling A, Meisner C, Wiestler B, Weller M; Neurooncology Working Group (NOA) of the German Cancer Society. Wick W, et al. Among authors: schmidt graf f. Neuro Oncol. 2016 Nov;18(11):1529-1537. doi: 10.1093/neuonc/now133. Epub 2016 Jul 1. Neuro Oncol. 2016. PMID: 27370396 Free PMC article. Clinical Trial.
Re-irradiation in elderly patients with glioblastoma: a single institution experience.
Straube C, Antoni S, Gempt J, Zimmer C, Meyer B, Schlegel J, Schmidt-Graf F, Combs SE. Straube C, et al. Among authors: schmidt graf f. J Neurooncol. 2019 Apr;142(2):327-335. doi: 10.1007/s11060-019-03101-6. Epub 2019 Jan 18. J Neurooncol. 2019. PMID: 30659523
Bessere Prognose von Low-grade-Gliomen durch Kombination von Bestrahlung, Procarbazin, CCNU und Vincristin.
Combs SE, Schmidt-Graf F, Meyer B. Combs SE, et al. Among authors: schmidt graf f. Strahlenther Onkol. 2016 Sep;192(9):672-4. doi: 10.1007/s00066-016-1016-6. Strahlenther Onkol. 2016. PMID: 27402390 Clinical Trial. German. No abstract available.
Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method.
von Rosenstiel C, Wiestler B, Haller B, Schmidt-Graf F, Gempt J, Bettstetter M, Rihani L, Wu W, Meyer B, Schlegel J, Liesche-Starnecker F. von Rosenstiel C, et al. Among authors: schmidt graf f. J Clin Pathol. 2020 Feb;73(2):112-115. doi: 10.1136/jclinpath-2019-206104. Epub 2019 Aug 17. J Clin Pathol. 2020. PMID: 31422371
The algorithms of adjuvant therapy in gliomas and their effect on survival.
Straube C, Schmidt-Graf F, Wiestler B, Zimmer C, Meyer B, Combs SE. Straube C, et al. Among authors: schmidt graf f. J Neurosurg Sci. 2019 Apr;63(2):179-186. doi: 10.23736/S0390-5616.18.04610-6. Epub 2018 Nov 8. J Neurosurg Sci. 2019. PMID: 30421895 Review.
Retrospective Analysis of Radiological Recurrence Patterns in Glioblastoma, Their Prognostic Value And Association to Postoperative Infarct Volume.
Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, Delbridge C, Gerhardt J, Zimmer C, Meyer B, Kirschke JS, Boeckh-Behrens T, Wiestler B, Gempt J. Bette S, et al. Among authors: schmidt graf f. Sci Rep. 2018 Mar 14;8(1):4561. doi: 10.1038/s41598-018-22697-9. Sci Rep. 2018. PMID: 29540809 Free PMC article.
A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 - results from a multi-center survey.
Straube C, Kessel KA, Schmidt-Graf F, Krieg SM, Meyer B, Gempt J, Combs SE. Straube C, et al. Among authors: schmidt graf f. BMC Cancer. 2018 Sep 21;18(1):907. doi: 10.1186/s12885-018-4825-4. BMC Cancer. 2018. PMID: 30241469 Free PMC article. Clinical Trial.
Dosimetric impact of tumor treating field (TTField) transducer arrays onto treatment plans for glioblastomas - a planning study.
Straube C, Oechsner M, Kampfer S, Scharl S, Schmidt-Graf F, Wilkens JJ, Combs SE. Straube C, et al. Among authors: schmidt graf f. Radiat Oncol. 2018 Feb 23;13(1):31. doi: 10.1186/s13014-018-0976-3. Radiat Oncol. 2018. PMID: 29471879 Free PMC article.
33 results
Jump to page
Feedback